Trials / Completed
CompletedNCT04638920
Molecular Breath Print of COPD Patients With Exacerbations Despite Triple Inhalational Therapy
Molecular Breath Print of COPD Patients With Exacerbations Despite Triple Inhalational Therapy (TripleEX)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 35 (actual)
- Sponsor
- Malcolm Kohler · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Determination of specific molecular breath patterns by secondary electrospray ionization mass spectrometry (SESIHRMS) during and 8 weeks after a COPD exacerbation. Furthermore, breath patterns will be assessed for correlation and association with clinical outcomes and treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No intervention |
Timeline
- Start date
- 2020-11-16
- Primary completion
- 2024-04-30
- Completion
- 2024-04-30
- First posted
- 2020-11-20
- Last updated
- 2025-04-02
- Results posted
- 2025-04-02
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04638920. Inclusion in this directory is not an endorsement.